Light exposure at night, sleep duration, melatonin, and breast cancer: A dose-response analysis of observational studies

European Journal of Cancer Prevention

Volumn 23, Issue 4, 2014, Pages 269-276

  Yang, Wan Shui ^a   Deng, Qin ^a   Fan, Wen Yan ^a   Wang, Wei Ye ^a   Wang, Xin ^a  

^a JIUJIANG UNIVERSITY   (China)

Author keywords

6 sulphatoxymelatonin; breast cancer; light at night; meta analysis; sleep duration

Indexed keywords

6 HYDROXYMELATONIN; 6-SULFATOXYMELATONIN; MELATONIN;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; EMBASE; HORMONE URINE LEVEL; HUMAN; LIGHT EXPOSURE; MEDICAL LITERATURE; MEDLINE; NIGHT SLEEP; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP TIME; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; LIGHT; META ANALYSIS; METABOLISM; PHYSIOLOGY; RISK FACTOR; SLEEP; SLEEP DISORDERS; STATISTICS AND NUMERICAL DATA; URINE;

BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LIGHT; MELATONIN; RISK FACTORS; SLEEP; SLEEP DISORDERS;

EID: 84902107791     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000030     Document Type: Article

References (39)

1. Bauer SE, Wagner SE, Burch J, Bayakly R, Vena JE (2013). A case-referent study: Light at night and breast cancer risk in Georgia. Int J Health Geogr 12:23
2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
3. Blask DE (2009). Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 13:257-264
4. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. (2005). Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65:11174-11184
5. Blask DE, Dauchy RT, Brainard GC, Hanifin JP (2009). Circadian stagedependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: Consequences of its disruption by light at night in rats and women. Integr Cancer Ther 8:347-353
6. Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, et al. (2011). Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 51:259-269
7. Brzezinski A (1997). Melatonin in humans. N Engl J Med 336:186-195
8. Davis S, Mirick DK, Stevens RG (2001). Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557-1562. (Pubitemid 32998485)
9. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188
10. Durrleman S, Simon R (1989). Flexible regression models with cubic splines. Stat Med 8:551-561
11. Girschik J, Heyworth J, Fritschi L (2013). Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol 177:316-327
12. Greenland S, Longnecker MP (1992). Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301-1309
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560
14. Jackson D, White IR, Thompson SG (2010). Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29:1282-1297
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61:69-90
16. Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A, Nakaya N, et al. (2008). Sleep duration and the risk of breast cancer: The Ohsaki Cohort Study. Br J Cancer 99:1502-1505
17. Kamdar BB, Tergas AI, Mateen FJ, Bhayani NH, Oh J (2013). Night-shift work and risk of breast cancer: A systematic review and meta-analysis. Breast Cancer Res Treat 138:291-301
18. Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA (2008). Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int 25:65-81
19. Kloog I, Stevens RG, Haim A, Portnov BA (2010). Nighttime light level codistributes with breast cancer incidence worldwide. Cancer Causes Control 21:2059-2068
20. Kloog I, Portnov BA, Rennert HS, Haim A (2011). Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol Int 28:76-80
21. Li Q, Zheng T, Holford TR, Boyle P, Zhang Y, Dai M (2010). Light at night and breast cancer risk: Results from a population-based case-control study in Connecticut, USA. Cancer Causes Control 21:2281-2285
22. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH (1975). Daily rhythm in human urinary melatonin. Science 187:169-171
23. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM (2006). Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 15:241-249. (Pubitemid 44215540)
24. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, et al. (2006). Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164:358-366. (Pubitemid 44297344)
25. Orsini N, Bellocco R, Greenland S (2006). Generalized least squares for trend estimation of summarized dose-response data. Stata J 6:40-57
26. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012). Meta-analysis for linear and nonlinear dose-response relations: Examples, an evaluation of approximations, and software. Am J Epidemiol 175:66-73
27. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006). A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66:5521-5525
28. Rajaratnam SM, Arendt J (2001). Health in a 24-h society. Lancet 358:999-1005
29. Schernhammer ES, Hankinson SE (2005). Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97:1084-1087. (Pubitemid 41417926)
30. Schernhammer ES, Hankinson SE (2009). Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 18:74-79
31. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. (2008). Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100:898-905. (Pubitemid 351881952)
32. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. (2010). Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: The ORDET cohort. Cancer Epidemiol Biomarkers Prev 19:729-737
33. Stevens RG (1987). Electric power use and breast cancer: A hypothesis. Am J Epidemiol 125:556-561
34. Stevens RG (2009). Light-at-night, circadian disruption and breast cancer: Assessment of existing evidence. Int J Epidemiol 38:963-970
35. Stevens RG, Davis S (1996). The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect 104 (Suppl 1):135-140
36. Travis RC, Allen DS, Fentiman IS, Key TJ (2004). Melatonin and breast cancer: A prospective study. J Natl Cancer Inst 96:475-482. (Pubitemid 38443651)
37. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005). Sleep duration and breast cancer: A prospective cohort study. Cancer Res 65:9595-9600
38. Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC (2008). Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29:1244-1248
39. Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM, Yu MC (2013). Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 132:891-896